FDA announces meetings on AI and generics The FDA, together with the Center for Research on Complex Generics, scheduled a meeting on October 1516 focused on opportunities, applications, and regulatory considerations of Artificial Intelligence (AI) in generic drug development and lifecycle management. They also published a slate of 2026 meetings, including one addressing how to navigate the generic GLP-1 pathway
For fibromyalgia or severe fatigue: Up to 4g/day, in divided doses, may be more effective
And if youre already a FLATTER ME loyalist this plays well with the whole lineup
CJC-1295 No DAC (5mg Vials x 10): Also biochemically classified as Modified GRF (1-29), this compound is a synthetic 29-amino-acid analog representing the fully functional biolytic fragment of endogenous GHRH, selectively optimized with four amino acid substitutions to resist rapid enzymatic cleaving by dipeptidyl peptidase-4 (DPP-4)
ahvma.org Preclinical safety/toxicology including dogs